SCHEMBL19995568

SCHEMBL19995568

CNC(=S)N1CC[C@@H](c2c(F)c(F)cc(F)c2F)C1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.43
NPC1 O15118 6/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
HTT P42858 3/20 0.40
ALDH1A1 P00352 2/20 0.40
GAA P10253 2/20 0.38
POLB P06746 1/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
MAPT P10636 2/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20006124 1.00 RAB9A (0.43) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19996150 0.81 PDE4B (0.42) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995887 0.81 PDE4B (0.42) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995563 0.78 RAB9A (0.59) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995584 0.78 RAB9A (0.59) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995974 0.72 RAB9A (0.63) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995523 0.72 RAB9A (0.63) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL28298518 0.68 QDPR (0.33)
SCHEMBL20005713 0.67 PDE4B (0.40) RAB9ANPC1SMN1; SMN2HTTALDH1A1
SCHEMBL19995527 0.67 PDE4B (0.40) RAB9ANPC1SMN1; SMN2HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515433-A1 BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-B-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2019-07-31 EP disclosed
WO-2018056854-A1 BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-B-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2018-03-29 WO disclosed